Latest Jpmorgan News

Page 3 of 4
JPMorgan Asset Management (Australia) Limited has announced the final cash distributions and reinvestment prices for several of its active ETFs for the financial year ended 30 June 2025, with payments scheduled for mid-July.
Claire Turing
Claire Turing
2 July 2025
JPMorgan Asset Management has released updated estimated cash distributions for five of its active ETFs for the financial year ended June 30, 2025, outlining key dates and investor participation details.
Claire Turing
Claire Turing
30 June 2025
JPMorgan Asset Management has announced the June 2025 distribution and provided detailed tax attribution estimates for its US 100Q Equity Premium Income Active ETF, highlighting key income components and withholding tax implications.
Claire Turing
Claire Turing
12 June 2025
Identitii Limited advances its BNDRY platform with new agreements targeting hospitality and payments sectors, appoints Tim Phillipps as Executive Chair, and reports stable cash flow amid ongoing patent litigation.
Sophie Babbage
Sophie Babbage
29 Apr 2025
JPMorgan Asset Management has announced updated estimated cash distributions for its Global Equity Premium Income ETFs for February 2025, providing investors with key dates and participation details.
Claire Turing
Claire Turing
14 Feb 2025
Light & Wonder, Inc. has amended its credit agreement to increase its revolving credit facility from $750 million to $1 billion, extend the maturity to 2030, and reduce interest margins based on leverage tests, enhancing its financial flexibility.
Sophie Babbage
Sophie Babbage
11 Feb 2025
JPMorgan Asset Management has announced estimated cash distributions for its Global Equity Premium Income ETFs for February 2025, alongside a detailed timetable for investors to follow.
Claire Turing
Claire Turing
10 Feb 2025
JPMorgan Asset Management has announced the final cash distributions for February 2025 across several of its active ETFs, providing investors with key dates and reinvestment options.
Claire Turing
Claire Turing
6 Feb 2025
AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.
Ada Torres
Ada Torres
6 Feb 2025
JPMorgan Asset Management has updated its February 2025 cash distribution amounts for several of its equity premium income ETFs, reinforcing its commitment to delivering steady income streams to investors.
Claire Turing
Claire Turing
4 Feb 2025
JPMorgan Asset Management has announced estimated cash distributions for its suite of equity premium income ETFs for February 2025, providing investors with key dates and payout expectations.
Claire Turing
Claire Turing
29 Jan 2025
JPMorgan Asset Management has announced estimated cash distributions for January 2025 across four key ETFs, signaling steady income opportunities for investors ahead of the new year.
Claire Turing
Claire Turing
2 Jan 2025

Browse the archive

Full archive